Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis

NJ Rhodes, J Liu, JN O'Donnell, JM Dulhunty… - Critical care …, 2018 - journals.lww.com
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …
被引用次数：107 相关文章

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis

NJ Rhodes, J Liu, JN O'Donnell… - Critical Care …, 2018 - ingentaconnect.com
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis

NJ Rhodes, J Liu, JN O'Donnell… - Critical care …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …

[引用][C] Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta …

NJ Rhodes, J Liu, JN O'Donnell… - Critical Care …, 2018 - espace.library.uq.edu.au
Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients; however,
controversy exists as to whether mortality in serious infections can be decreased through …

Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis.

NJ Rhodes, LJJ Liu JiaJun, JN O'Donnell, JM Dulhunty… - 2018 - cabidigitallibrary.org
Objective: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …

Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis.

NJ Rhodes, J Liu, JN O'Donnell, JM Dulhunty… - Critical Care …, 2018 - europepmc.org
OBJECTIVE: Piperacillin-tazobactam is a commonly used antibiotic in critically ill patients;
however, controversy exists as to whether mortality in serious infections can be decreased …